Primer Mitokondriyal Hastalıkların Görüntüleme Bulguları

Bock FJ, Tait SWG. Mitochondria as multifaceted regulatorsof cell death. Nat Rev Mol Cell Biol 2020;21(2):85–100.

Zolkipli-Cunningham Z, Xiao R, Stoddart A, McCormick EM, Holberts A, Burrill N. Mito-chondrial disease patient motivations and barriers to par-ticipate in clinical trials. PLoS One 2018;13(5)

Lake NJ, Compton AG, Rahman S, Thorburn DR. Leighsyndrome: one disorder, more than 75 monogenic causes.Ann Neurol 2016;79(2):190–203

Sofou K, De Coo IF, Isohanni P, Ostergaard E, Naess K, De Meirleir L, et al. A multicenterstudy on Leigh syndrome: disease course and predictors ofsurvival. Orphanet J Rare Dis 2014;9(1):52

Alves CAPF, Teixeira SR, Martin-Saavedra JS, Guimarães Gonçalves F, Lo Russo F, Muraresku C, et al. Pe-diatric leigh syndrome: neuroimaging features and geneticcorrelations. Ann Neurol 2020;88(2):218–232

Hikmat O, Eichele T, Tzoulis C, Bindoff LA. Understanding the epilepsy in POLG related disease. Int J Mol Sci 2017;18(9):E1845.

Anagnostou ME, Ng YS, Taylor RW, McFarland R. Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: a clinical and molecular genetic review. Epilepsia 2016;57(10):1531–1545.

Gonçalves FG, Hill B, Guo Y, Muraresku CC, McCormick E, Alves CAPF, et al. The Perirolandic Sign: A Unique Imaging Finding Observed in Association with Polymerase γ-Related Disorders. AJNR Am J Neuroradiol 2020;41(5):917–922.

Goodfellow JA, Dani K, Stewart W, Santosh C, McLean J, Mulhern S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people. Postgrad Med J 2012;88(1040):326–334

Allard JC, Tilak S, Carter AP. CT and MR of MELAS syndrome. AJNR Am J Neuroradiol 1988;9(6):1234–1238

Kim IO, Kim JH, Kim WS, Hwang YS, Yeon KM, Han MC. Mitochondrial myopathy-encephalopathy-lactic acidosis-and strokelike episodes (MELAS) syndrome: CT and MR findings in seven children. AJR Am J Roentgenol 1996;166(3):641–645

Ito H, Mori K, Harada M, Minato M, Naito E, Takeuchi M, et al. Serial brain imaging analysis of stroke-like episodes in MELAS. Brain Dev 2008;30(7):483–488.

Liu Z, Zheng D, Wang X, Zhang J, Xie S, Xiao J, et al. Apparent diffusion coefficients of metabolites in patients with MELAS using diffusion-weighted MR spectroscopy. AJNR Am J Neuroradiol 2011;32(5):898–902.

Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol 1994;9(1):4–13.

Adam G, Ferrier M, Patsoura S, Gramada R, Meluchova Z, Cazzola V, et al. Magnetic resonance imaging of arterial stroke mimics: a pictorial review. Insights Imaging 2018;9(5):815–831

Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38(9):1339–1346.

Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008;63(1):35–39

Yu M, Zhang Z, Wang QQ, et al. Clinical and Brain Magnetic Resonance Imaging Features in a Cohort of Chinese Patients with Kearns-Sayre Syndrome. Chin Med J (Engl) 2016;129(12):1419–1424.

Yu M, Zhang Z, Wang QQ, Liu J, Zuo YH, Yu L, et al. Clinical and Brain Magnetic Resonance Imaging Features in a Cohort of Chinese Patients with Kearns-Sayre Syndrome. Chin Med J (Engl) 2016;129(12):1419–1424

Schiffmann R, van der Knaap MS. Invited article: an MRIbased approach to the diagnosis of white matter disorders. Neurology 2009;72(8):750–759.

Jurkute N, Yu-Wai-Man P. Leber hereditary optic neuropathy: bridging the translational gap. Curr Opin Ophthalmol 2017;28(5):403–409.

La Morgia C, Carbonelli M, Barboni P, Sadun AA, Carelli V. Medical management of hereditary optic neuropathies. Front Neurol 2014;5:141

Mashima Y, Oshitari K, Imamura Y, Momoshima S, Shiga H, Oguchi Y. Orbital high resolution magnetic resonance imaging with fast spin echo in the acute stage of Leber’s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1998;64(1):124–127

Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM, et al. Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 2000;15(3):209–219.

Patel KP, O’Brien TW, Subramony SH, Shuster J, Stacpoole PW. The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab 2012;106(3):385–394.

Alves CAPF, Teixeira SR, Goncalves FG, Zuccoli G. Neuroimaging findings in primary mitochondrial cytopathies. In: Mancuso M, Klopstock T, eds. Diagnosis and management of mitochondrial disorders. Cham, Switzerland: Springer, 2019; 289–316.

Trevisson E, DiMauro S, Navas P, Salviati L. Coenzyme Q deficiency in muscle. Curr Opin Neurol 2011;24(5):449–456.

Goldstein AC, Bhatia P, Vento JM. Mitochondrial disease in childhood: nuclear encoded. Neurotherapeutics 2013;10(2):212–226

Laugwitz L, Seibt A, Herebian D, Peralta S, Kienzle I, Buchert R, et al. Human COQ4 deficiency: delineating the clinical, metabolic and neuroimaging phenotypes. J Med Genet. 2022 Sep;59(9):878-887

van Berge L, Hamilton EM, Linnankivi T, Uziel G, Steenweg ME, Isohanni P, et al. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy. Brain 2014;137(Pt 4):1019–1029.

Steenweg ME, van Berge L, van Berkel CG, de Coo IF, Temple IK, Brockmann K, et al. Early-onset LBSL: how severe does it get? Neuropediatrics 2012;43(6):332–338.